Analysts are significantly more bearish about TrueBlue's prospects, given the considerable drop in revenue and EPS estimates. The expectation that the company's revenues will decline faster than the wider industry further compels a negative outlook for TrueBlue.
TrueBlue Stock Forum
• $Macy's (M.US)$ +13.2% (Macy's posts strong sales growth and raises earnings outlook)
• $Dollar Tree (DLTR.US)$ +12.7% (In reaction to earnings)
• $Dollar General (DG.US)$ +11.1% (Dollar Gen beat estimated earnings by 3.88%, reporting an EPS of $2.41 versus an estimate of $2.32.)
• $Williams-Sonoma (WSM.US)$ +8.4% (In reaction to earnings)
• $Akoustis Technologies (AKTS.US)$ +6.1% (suspended sales under its previously-announced "...
• $AmerisourceBergen (ABC.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare (ALHC.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $Cigna Group (CI.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway (CNI.US)$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao (DAO.US)$ : Citic Securities Upgrades to Buy from Neut...
No comment yet